Explore how PET radiopharmaceuticals are revolutionizing personalized medicine through molecular imaging and theranostics approaches.
Exploring phospa-trastuzumab, a bifunctional methylenephosphonate-based chelator that's advancing cancer theranostics with radiometals 89Zr, 111In, and 177Lu.
Innovative bifunctional molecules that combine diagnostic imaging and targeted radiotherapy for metastatic melanoma treatment.